Nat Rev BioengJClub
AI-enabled clinical trials.
Nature Reviews Bioengineering · · Journal Article · Open access
Raynaud, Trayanova + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
An AI-enabled clinical trial engineering framework proposes four stages—data tools, fit-to-question matching, AI-supported conduct, and faster go/no-go decisions—across specialties to streamline RCTs.
- Why it matters: Randomized controlled trials face high costs, restrictive eligibility, recruitment and long follow-up burdens, and poorly designed studies that add noise to the literature.
- What they did: The Review outlines an AI framework using fit-for-purpose validation plus continuous regulatory engagement and human oversight, illustrated with iBox, annualized relapse rate, heart digital twins, AIM-MASH, and a large language model.
- The result: Used judiciously, AI-enabled trials could shorten timelines, reduce costs, accelerate identification of effective therapies, and enable earlier elimination of futile ones.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- Open access
- 2 cites
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.